BARNWELL INDUSTRIES INC (BRN)

US0682211000 - Common Stock

2.91  +0.2 (+7.38%)

Fundamental Rating

3

Taking everything into account, BRN scores 3 out of 10 in our fundamental rating. BRN was compared to 214 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of BRN is average, but there are quite some concerns on its profitability. BRN has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year BRN has reported negative net income.
BRN had a positive operating cash flow in the past year.
In multiple years BRN reported negative net income over the last 5 years.
Of the past 5 years BRN 4 years had a positive operating cash flow.

1.2 Ratios

BRN's Return On Assets of -7.75% is on the low side compared to the rest of the industry. BRN is outperformed by 90.14% of its industry peers.
BRN has a Return On Equity of -14.95%. This is amonst the worse of the industry: BRN underperforms 87.79% of its industry peers.
Industry RankSector Rank
ROA -7.75%
ROE -14.95%
ROIC N/A
ROA(3y)12.56%
ROA(5y)-12.29%
ROE(3y)29.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 34.09%, BRN is in line with its industry, outperforming 41.31% of the companies in the same industry.
BRN's Gross Margin has improved in the last couple of years.
BRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y1.55%

5

2. Health

2.1 Basic Checks

BRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BRN has more shares outstanding than it did 1 year ago.
BRN has more shares outstanding than it did 5 years ago.
BRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 1.67, we must say that BRN is in the distress zone and has some risk of bankruptcy.
BRN has a Altman-Z score of 1.67. This is comparable to the rest of the industry: BRN outperforms 51.64% of its industry peers.
There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.67
ROIC/WACCN/A
WACC9.29%

2.3 Liquidity

A Current Ratio of 1.37 indicates that BRN should not have too much problems paying its short term obligations.
BRN has a Current ratio (1.37) which is in line with its industry peers.
BRN has a Quick Ratio of 1.37. This is a normal value and indicates that BRN is financially healthy and should not expect problems in meeting its short term obligations.
BRN has a Quick ratio of 1.37. This is in the better half of the industry: BRN outperforms 68.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37

2

3. Growth

3.1 Past

BRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -148.29%.
The Revenue for BRN has decreased by -19.33% in the past year. This is quite bad
Measured over the past years, BRN shows a very strong growth in Revenue. The Revenue has been growing by 21.68% on average per year.
EPS 1Y (TTM)-148.29%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-160.73%
Revenue 1Y (TTM)-19.33%
Revenue growth 3Y11.51%
Revenue growth 5Y21.68%
Revenue growth Q2Q-15.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

BRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BRN is valued a bit more expensive than the industry average as 71.83% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.78

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

BRN has a Yearly Dividend Yield of 2.15%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.79, BRN has a dividend in line with its industry peers.
BRN's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.15%

5.2 History

The dividend of BRN decreases each year by -19.19%.
BRN has been paying a dividend for at least 10 years, so it has a reliable track record.
BRN has decreased its dividend recently.
Dividend Growth(5Y)-19.19%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

The earnings of BRN are negative and hence is the payout ratio. BRN will probably not be able to sustain this dividend level.
DP-22.07%
EPS Next 2YN/A
EPS Next 3YN/A

BARNWELL INDUSTRIES INC

NYSEARCA:BRN (4/25/2024, 7:04:01 PM)

2.91

+0.2 (+7.38%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap29.27M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.15%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.75%
ROE -14.95%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 34.09%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-148.29%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-19.33%
Revenue growth 3Y11.51%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y